Convalescent Plasma as a Possible Treatment for COVID-19

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 5, 2020

Primary Completion Date

May 5, 2021

Study Completion Date

May 5, 2021

Conditions
COVID-19
Interventions
BIOLOGICAL

Convalescent plasma

This study will use convalescent plasma collected from those who have previously had COVID-19 and have been shown to have cleared the infection and made antibodies against the virus.

BIOLOGICAL

Placebo

The placebo arm of this study will use fresh frozen plasma that presumably does not contain antibodies against COVID-19.

Trial Locations (1)

60612

RECRUITING

University of Illinois at Chicago, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER